Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: Cytotherapy. 2011 May 4;13(8):976–986. doi: 10.3109/14653249.2011.575356

Figure 4.

Figure 4

Cytolytic function of Ad5f35-IE-1-I-pp65 T cells. (a, b) 51Cr release after 4 h of co-incubation of autologous EBV LCL with CMV-IE-1, CMV-pp65 and Ad-hexon/penton pepmix or EBV LCL alone with Ad5f35-IE-1-I-pp65 T cells. The data are the percentage of lysis at E:T ratios of 40:1, 20:1, 10:1, and 5:1. (c) 51Cr release after 6 h of incubating Ad5f35-IE-I-I-pp65 T cells with allogeneic HLA-A2 + CMV AD169-infected or uninfected fibroblasts. Error bars indicate the standard deviation of the triplicates.